Illumina, Inc. recalls NovaSeq 6000Dx including DRAGEN Server
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Retrospectively reported correction for an instrument intended for targeted sequencing of DNA libraries from human genomic DNA used with in vitro diagnostic assays has a server with a security vulnerability.
- Products
-
- NovaSeq 6000Dx including DRAGEN Server
- Company
- Illumina, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution in the states of TX, KS, NC, CA, UT, KA, MA, NJ, MD and the countries of Spain, South Korea, Japan, Australia, Italy, United Arab Emirates, Sweden, United Kingdom, Czech Republic, Singapore, Austria, Poland, France, Germany, Finland, Switzerland, Slovakia.
States: California, Kansas, Massachusetts, Maryland, North Carolina, New Jersey, Texas, Utah
- Units affected
- 80
- About this recall
- NovaSeq 6000Dx including DRAGEN Server, Catalog Number: 20068232; Illumina DRAGEN Server for NextSeq 550Dx, Catalog Number: 20086130